Pure Global AI
HSA · registration DE0509521

Abbott Diagnostics Medical Determine™ HBsAg 2

SingaporeImmunologyClass DAbbott Diagnostics Medical Co., Ltd.
Official record identity
Registration number
DE0509521
Model name
Determine™ HBsAg 2; Determine™ HBsAg 2
Model identifier
7D2942; 7D2943
Registration date
July 12, 2024
Classification
Risk class
Class D
Official value: CLASS D
Published category
Immunology
Published parties
Official description

Determine™ HBsAg 2 is an in vitro, visually read, qualitative immunoassay for the detection of Hepatitis B Surface Antigen (HBsAg) in human capillary and venous whole blood, plasma or serum. The test is intended as an aid in the diagnosis of HBV infection through detection of HBsAg from infected individuals. The test is not intended for screening blood donors. The test is for professional use only.

Additional source fields
Product owner address
357 Matsuhidai,, Matsudo-shi, Chiba,, 270-2214, Japan
Registrant address
3 FRASER STREET, #23-28, DUO TOWER, Singapore 189352
About this record

This page mirrors one row from HSA’s official registered-medical-device workbook. Product owner and registrant are separate published roles; neither is relabeled as the manufacturer. The official NOT_GENERATED value is retained when HSA does not publish a registration number, and the device name remains part of the stable record identity.